ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Hippo pathway deregulation in myeloproliferative neoplasms (2017)
Cacemiro, Maira da Costa; Cominal, Juçara Gastaldi; Souto, Elizabeth Xisto; Traina, Fabiola; Pontes, Lorena Lobo de Figueiredo; Simões, Belinda Pinto; Castro, Fabíola Attié de
Source: Revista Brasileira de Hematologia e Hemoterapia. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HEMO 2017). Unidades: FMRP, FCFRP
Subjects: NEOPLASIAS, LEUCEMIA, PROLIFERAÇÃO CELULAR, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CACEMIRO, Maira da Costa et al. Hippo pathway deregulation in myeloproliferative neoplasms. Revista Brasileira de Hematologia e Hemoterapia. Rio de Janeiro: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://www.abhheventos.com.br/hemo2017/wp-content/uploads/2014/01/SUPLEMENTO-HEMO-2017.pdf. Acesso em: 06 nov. 2024. , 2017
APA
Cacemiro, M. da C., Cominal, J. G., Souto, E. X., Traina, F., Pontes, L. L. de F., Simões, B. P., & Castro, F. A. de. (2017). Hippo pathway deregulation in myeloproliferative neoplasms. Revista Brasileira de Hematologia e Hemoterapia. Rio de Janeiro: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://www.abhheventos.com.br/hemo2017/wp-content/uploads/2014/01/SUPLEMENTO-HEMO-2017.pdf
NLM
Cacemiro M da C, Cominal JG, Souto EX, Traina F, Pontes LL de F, Simões BP, Castro FA de. Hippo pathway deregulation in myeloproliferative neoplasms [Internet]. Revista Brasileira de Hematologia e Hemoterapia. 2017 ; 39 S160-S161.[citado 2024 nov. 06 ] Available from: https://www.abhheventos.com.br/hemo2017/wp-content/uploads/2014/01/SUPLEMENTO-HEMO-2017.pdf
Vancouver
Cacemiro M da C, Cominal JG, Souto EX, Traina F, Pontes LL de F, Simões BP, Castro FA de. Hippo pathway deregulation in myeloproliferative neoplasms [Internet]. Revista Brasileira de Hematologia e Hemoterapia. 2017 ; 39 S160-S161.[citado 2024 nov. 06 ] Available from: https://www.abhheventos.com.br/hemo2017/wp-content/uploads/2014/01/SUPLEMENTO-HEMO-2017.pdf
Artigo de periodico
Defective expression of apoptosis-related molecules in multiple sclerosis patients is normalized early after autologous haematopoietic stem cell transplantation (2017)
Oliveira, G. L. V. de; Ferreira, A. F.; Gasparotto, E. P. L.; Kashima, S.; Covas, Dimas Tadeu; Gueirreiro, C. T.; Brum, D. G.; Barreira, Amilton Antunes; Voltarelli, Júlio César; Simões, Belinda Pinto; Oliveira, M. C.; Castro, F. A. de; Malmegrim, K. C. R.
Source: Clinical and Experimental Immunology. Unidade: FMRP
Subjects: APOPTOSE, LINFÓCITOS T, EXPRESSÃO GÊNICA, ESCLEROSE MÚLTIPLA, TRANSPLANTE AUTÓLOGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, G. L. V. de et al. Defective expression of apoptosis-related molecules in multiple sclerosis patients is normalized early after autologous haematopoietic stem cell transplantation. Clinical and Experimental Immunology, v. 187, n. 3, p. 383-398, 2017Tradução . . Disponível em: https://doi.org/10.1111/cei.12895. Acesso em: 06 nov. 2024.
APA
Oliveira, G. L. V. de, Ferreira, A. F., Gasparotto, E. P. L., Kashima, S., Covas, D. T., Gueirreiro, C. T., et al. (2017). Defective expression of apoptosis-related molecules in multiple sclerosis patients is normalized early after autologous haematopoietic stem cell transplantation. Clinical and Experimental Immunology, 187( 3), 383-398. doi:10.1111/cei.12895
NLM
Oliveira GLV de, Ferreira AF, Gasparotto EPL, Kashima S, Covas DT, Gueirreiro CT, Brum DG, Barreira AA, Voltarelli JC, Simões BP, Oliveira MC, Castro FA de, Malmegrim KCR. Defective expression of apoptosis-related molecules in multiple sclerosis patients is normalized early after autologous haematopoietic stem cell transplantation [Internet]. Clinical and Experimental Immunology. 2017 ; 187( 3): 383-398.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1111/cei.12895
Vancouver
Oliveira GLV de, Ferreira AF, Gasparotto EPL, Kashima S, Covas DT, Gueirreiro CT, Brum DG, Barreira AA, Voltarelli JC, Simões BP, Oliveira MC, Castro FA de, Malmegrim KCR. Defective expression of apoptosis-related molecules in multiple sclerosis patients is normalized early after autologous haematopoietic stem cell transplantation [Internet]. Clinical and Experimental Immunology. 2017 ; 187( 3): 383-398.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1111/cei.12895
Trabalho de evento-resumo periodico
Activation of IRS1/beta-catenin axis in acute lymphoblastic leukemia (2016)
Fernandes, J. C; Alves, A. P. N. Rodrigues; Machado Neto, João Agostinho ; Scopim-Ribeiro, R; Fenerich, B. Alves; Silva, F. Borges da; Simões, Belinda Pinto; Rego, Eduardo Magalhães; Traina, Fabiola
Source: Haematologica. Conference titles: Congress of the European Hematology Association (EHA). Unidade: FMRP
Subjects: LEUCEMIA, EXPRESSÃO GÊNICA, PROTEÍNA 1 DE LIGAÇÃO AOS FATORES DE CRESCIMENTO INSULIN-LIKE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, J. C et al. Activation of IRS1/beta-catenin axis in acute lymphoblastic leukemia. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: http://www.haematologica.org/content/101/s1/1.full.pdf+html. Acesso em: 06 nov. 2024. , 2016
APA
Fernandes, J. C., Alves, A. P. N. R., Machado Neto, J. A., Scopim-Ribeiro, R., Fenerich, B. A., Silva, F. B. da, et al. (2016). Activation of IRS1/beta-catenin axis in acute lymphoblastic leukemia. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Recuperado de http://www.haematologica.org/content/101/s1/1.full.pdf+html
NLM
Fernandes JC, Alves APNR, Machado Neto JA, Scopim-Ribeiro R, Fenerich BA, Silva FB da, Simões BP, Rego EM, Traina F. Activation of IRS1/beta-catenin axis in acute lymphoblastic leukemia [Internet]. Haematologica. 2016 ; 101 654.[citado 2024 nov. 06 ] Available from: http://www.haematologica.org/content/101/s1/1.full.pdf+html
Vancouver
Fernandes JC, Alves APNR, Machado Neto JA, Scopim-Ribeiro R, Fenerich BA, Silva FB da, Simões BP, Rego EM, Traina F. Activation of IRS1/beta-catenin axis in acute lymphoblastic leukemia [Internet]. Haematologica. 2016 ; 101 654.[citado 2024 nov. 06 ] Available from: http://www.haematologica.org/content/101/s1/1.full.pdf+html
Artigo de periodico
Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients (2015)
Arruda, L. C. M.; Lorenzi, J. C. C.; Sousa, A. P. A.; Zanette, D. L.; Palma, P. V. B.; Panepucci, Rodrigo Alexandre; Brum, D. S.; Barreira, Amilton Antunes; Covas, Dimas Tadeu; Simões, Belinda Pinto; Silva Júnior, Wilson Araújo da; Oliveira, M. C.; Malmegrim, K. C. R.
Source: Bone Marrow Transplantation. Unidade: FMRP
Subjects: ESCLEROSE MÚLTIPLA, CÉLULAS-TRONCO (TRANSPLANTE), EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARRUDA, L. C. M. et al. Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients. Bone Marrow Transplantation, v. 50, n. 3, p. 380-389, 2015Tradução . . Disponível em: https://doi.org/10.1038/bmt.2014.277. Acesso em: 06 nov. 2024.
APA
Arruda, L. C. M., Lorenzi, J. C. C., Sousa, A. P. A., Zanette, D. L., Palma, P. V. B., Panepucci, R. A., et al. (2015). Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients. Bone Marrow Transplantation, 50( 3), 380-389. doi:10.1038/bmt.2014.277
NLM
Arruda LCM, Lorenzi JCC, Sousa APA, Zanette DL, Palma PVB, Panepucci RA, Brum DS, Barreira AA, Covas DT, Simões BP, Silva Júnior WA da, Oliveira MC, Malmegrim KCR. Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients [Internet]. Bone Marrow Transplantation. 2015 ; 50( 3): 380-389.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1038/bmt.2014.277
Vancouver
Arruda LCM, Lorenzi JCC, Sousa APA, Zanette DL, Palma PVB, Panepucci RA, Brum DS, Barreira AA, Covas DT, Simões BP, Silva Júnior WA da, Oliveira MC, Malmegrim KCR. Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients [Internet]. Bone Marrow Transplantation. 2015 ; 50( 3): 380-389.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1038/bmt.2014.277
Artigo de periodico
Autologous haematopoietic stem cell transplantation reduces abnormalities in the expression of immune genes in multiple sclerosis (2015)
Sousa, Alessandra de Paula; Malmegrim, Kelen C.; Panepucci, Rodrigo A.; Brum, Doralina S.; Barreira, Amilton Antunes; Santos, Antônio Carlos dos; Araújo, Amélia Goes; Covas, Dimas Tadeu; Oliveira, Maria C.; Moraes, Daniela A.; Pieroni, Fabiano; Barros, George M.; Simões, Belinda Pinto; Nicholas, Richard; Burt, Richard K.; Voltarelli, Julio Cesar; Muraro, Paolo A.
Source: Clinical Science. Unidade: FMRP
Subjects: EXPRESSÃO GÊNICA, REGULAÇÃO GÊNICA, CÉLULAS-TRONCO (TRANSPLANTE), ESCLEROSE MÚLTIPLA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA, Alessandra de Paula et al. Autologous haematopoietic stem cell transplantation reduces abnormalities in the expression of immune genes in multiple sclerosis. Clinical Science, v. 128, n. 2, p. 111-120, 2015Tradução . . Disponível em: https://doi.org/10.1042/CS20140095. Acesso em: 06 nov. 2024.
APA
Sousa, A. de P., Malmegrim, K. C., Panepucci, R. A., Brum, D. S., Barreira, A. A., Santos, A. C. dos, et al. (2015). Autologous haematopoietic stem cell transplantation reduces abnormalities in the expression of immune genes in multiple sclerosis. Clinical Science, 128( 2), 111-120. doi:10.1042/CS20140095
NLM
Sousa A de P, Malmegrim KC, Panepucci RA, Brum DS, Barreira AA, Santos AC dos, Araújo AG, Covas DT, Oliveira MC, Moraes DA, Pieroni F, Barros GM, Simões BP, Nicholas R, Burt RK, Voltarelli JC, Muraro PA. Autologous haematopoietic stem cell transplantation reduces abnormalities in the expression of immune genes in multiple sclerosis [Internet]. Clinical Science. 2015 ; 128( 2): 111-120.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1042/CS20140095
Vancouver
Sousa A de P, Malmegrim KC, Panepucci RA, Brum DS, Barreira AA, Santos AC dos, Araújo AG, Covas DT, Oliveira MC, Moraes DA, Pieroni F, Barros GM, Simões BP, Nicholas R, Burt RK, Voltarelli JC, Muraro PA. Autologous haematopoietic stem cell transplantation reduces abnormalities in the expression of immune genes in multiple sclerosis [Internet]. Clinical Science. 2015 ; 128( 2): 111-120.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1042/CS20140095
Artigo de periodico
Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts (2015)
Oliveira, Gislane Lelis Vilela de; Lima, Kalil William Alves de; Colombini, Amanda M.; Pinheiro, Daniel Guariz; Panepucci, Rodrigo Alexandre; Palma, Patricia Vianna Bonini; Brum, Doralina Guimarães; Covas, Dimas Tadeu; Simões, Belinda Pinto; Oliveira, Maria C. de; Donadi, Eduardo Antônio; Malmegrim, Kelen C. R.
Source: Cell Transplantation: the regenerative medicine journal. Unidade: FMRP
Subjects: ESCLEROSE MÚLTIPLA, EXPRESSÃO GÊNICA, ADJUVANTES IMUNOLÓGICOS, IMUNOSSUPRESSÃO, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Gislane Lelis Vilela de et al. Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts. Cell Transplantation: the regenerative medicine journal, v. 24, n. 2, p. 151–165, 2015Tradução . . Disponível em: https://doi.org/10.3727/096368913X675142. Acesso em: 06 nov. 2024.
APA
Oliveira, G. L. V. de, Lima, K. W. A. de, Colombini, A. M., Pinheiro, D. G., Panepucci, R. A., Palma, P. V. B., et al. (2015). Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts. Cell Transplantation: the regenerative medicine journal, 24( 2), 151–165. doi:10.3727/096368913X675142
NLM
Oliveira GLV de, Lima KWA de, Colombini AM, Pinheiro DG, Panepucci RA, Palma PVB, Brum DG, Covas DT, Simões BP, Oliveira MC de, Donadi EA, Malmegrim KCR. Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts [Internet]. Cell Transplantation: the regenerative medicine journal. 2015 ; 24( 2): 151–165.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3727/096368913X675142
Vancouver
Oliveira GLV de, Lima KWA de, Colombini AM, Pinheiro DG, Panepucci RA, Palma PVB, Brum DG, Covas DT, Simões BP, Oliveira MC de, Donadi EA, Malmegrim KCR. Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts [Internet]. Cell Transplantation: the regenerative medicine journal. 2015 ; 24( 2): 151–165.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3727/096368913X675142
Artigo de periodico
ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance (2014)
Ferreira, A. F.; Moura, L. G.; Tojal, I.; Ambrósio, L.; Simões, Belinda Pinto; Hamerschlak, N.; Calin, G. A.; Ivan, C.; Covas, Dimas Tadeu; Kashima, Simone; Castro, Fabíola Attié de
Source: Blood Cells, Molecules and Diseases. Unidades: FMRP, FCFRP
Subjects: LEUCEMIA MIELOIDE AGUDA, APOPTOSE, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, A. F. et al. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance. Blood Cells, Molecules and Diseases, v. 53, n. 1-2, p. 47-55, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.bcmd.2014.02.008. Acesso em: 06 nov. 2024.
APA
Ferreira, A. F., Moura, L. G., Tojal, I., Ambrósio, L., Simões, B. P., Hamerschlak, N., et al. (2014). ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance. Blood Cells, Molecules and Diseases, 53( 1-2), 47-55. doi:10.1016/j.bcmd.2014.02.008
NLM
Ferreira AF, Moura LG, Tojal I, Ambrósio L, Simões BP, Hamerschlak N, Calin GA, Ivan C, Covas DT, Kashima S, Castro FA de. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance [Internet]. Blood Cells, Molecules and Diseases. 2014 ; 53( 1-2): 47-55.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.bcmd.2014.02.008
Vancouver
Ferreira AF, Moura LG, Tojal I, Ambrósio L, Simões BP, Hamerschlak N, Calin GA, Ivan C, Covas DT, Kashima S, Castro FA de. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance [Internet]. Blood Cells, Molecules and Diseases. 2014 ; 53( 1-2): 47-55.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.bcmd.2014.02.008
Artigo de periodico-carta/editorial
Differential expression of apopttomiRs in myeloproliferative neoplasms. [Carta] (2013)
Nunes, Natália S; Tognon, Raquel; Moura, Livia G.; Kashima, Simone; Covas, Dimas Tadeu; Santana, Mary; Souto, Elizabeth X.; Zanichelli, Maria A.; Simoes, Belinda Pinto; Souza, Ana Maria de; Castro, Fabíola Attié de
Source: Leukemia and Lymphoma. Unidades: FMRP, FCFRP
Subjects: EXPRESSÃO GÊNICA, APOPTOSE, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NUNES, Natália S et al. Differential expression of apopttomiRs in myeloproliferative neoplasms. [Carta]. Leukemia and Lymphoma. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.3109/10428194.2013.767453. Acesso em: 06 nov. 2024. , 2013
APA
Nunes, N. S., Tognon, R., Moura, L. G., Kashima, S., Covas, D. T., Santana, M., et al. (2013). Differential expression of apopttomiRs in myeloproliferative neoplasms. [Carta]. Leukemia and Lymphoma. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.3109/10428194.2013.767453
NLM
Nunes NS, Tognon R, Moura LG, Kashima S, Covas DT, Santana M, Souto EX, Zanichelli MA, Simoes BP, Souza AM de, Castro FA de. Differential expression of apopttomiRs in myeloproliferative neoplasms. [Carta] [Internet]. Leukemia and Lymphoma. 2013 ; 54( 9): 2047-2051.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3109/10428194.2013.767453
Vancouver
Nunes NS, Tognon R, Moura LG, Kashima S, Covas DT, Santana M, Souto EX, Zanichelli MA, Simoes BP, Souza AM de, Castro FA de. Differential expression of apopttomiRs in myeloproliferative neoplasms. [Carta] [Internet]. Leukemia and Lymphoma. 2013 ; 54( 9): 2047-2051.[citado 2024 nov. 06 ] Available from: https://doi.org/10.3109/10428194.2013.767453
Artigo de periodico
Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in essential thrombocythemia and myelofibrosis (2012)
Tognon, Raquel; Gasparotto, Elainy P. L.; Neves, Renata P.; Nunes, Natália S.; Ferreira, Aline F.; Palma, Patrícia V. B.; Kashima, Simone; Covas, Dimas Tadeu; Santana, Mary; Souto, Elizabeth X.; Zanichelli, Maria Aparecida; Simoes, Belinda Pinto; Souza, Ana Maria de; Castro, Fabíola Attié de
Source: Journal of Hematology and Oncology. Unidades: FMRP, FCFRP
Subjects: APOPTOSE, PROTEÍNAS DA MEMBRANA (METABOLISMO), EXPRESSÃO GÊNICA, WESTERN BLOTTING, METAPLASIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOGNON, Raquel et al. Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in essential thrombocythemia and myelofibrosis. Journal of Hematology and Oncology, v. 5, 2012Tradução . . Disponível em: https://doi.org/10.1186/1756-8722-5-2. Acesso em: 06 nov. 2024.
APA
Tognon, R., Gasparotto, E. P. L., Neves, R. P., Nunes, N. S., Ferreira, A. F., Palma, P. V. B., et al. (2012). Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in essential thrombocythemia and myelofibrosis. Journal of Hematology and Oncology, 5. doi:10.1186/1756-8722-5-2
NLM
Tognon R, Gasparotto EPL, Neves RP, Nunes NS, Ferreira AF, Palma PVB, Kashima S, Covas DT, Santana M, Souto EX, Zanichelli MA, Simoes BP, Souza AM de, Castro FA de. Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in essential thrombocythemia and myelofibrosis [Internet]. Journal of Hematology and Oncology. 2012 ; 5[citado 2024 nov. 06 ] Available from: https://doi.org/10.1186/1756-8722-5-2
Vancouver
Tognon R, Gasparotto EPL, Neves RP, Nunes NS, Ferreira AF, Palma PVB, Kashima S, Covas DT, Santana M, Souto EX, Zanichelli MA, Simoes BP, Souza AM de, Castro FA de. Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in essential thrombocythemia and myelofibrosis [Internet]. Journal of Hematology and Oncology. 2012 ; 5[citado 2024 nov. 06 ] Available from: https://doi.org/10.1186/1756-8722-5-2
Trabalho de evento-resumo periodico
PRV-1 overexpression in essential thrombocythemia correlates with trail expression (2011)
Tognon, R.; Neves, R.; Nunes, N.; Gasparotto, E.; Kashima, S.; Covas, Dimas Tadeu; Santana, M.; Souto, E.; Zanichelli, M.; Velano, C.; Simoes, Belinda Pinto; Souza, Ana Maria de; Castro, Fabíola Attié de
Source: Haematologica. Conference titles: Congress of The European Hematology Association. Unidades: FMRP, FCFRP
Subjects: EXPRESSÃO GÊNICA, DOENÇAS HEMATOLÓGICAS, LEUCÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOGNON, R. et al. PRV-1 overexpression in essential thrombocythemia correlates with trail expression. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 06 nov. 2024. , 2011
APA
Tognon, R., Neves, R., Nunes, N., Gasparotto, E., Kashima, S., Covas, D. T., et al. (2011). PRV-1 overexpression in essential thrombocythemia correlates with trail expression. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Tognon R, Neves R, Nunes N, Gasparotto E, Kashima S, Covas DT, Santana M, Souto E, Zanichelli M, Velano C, Simoes BP, Souza AM de, Castro FA de. PRV-1 overexpression in essential thrombocythemia correlates with trail expression. Haematologica. 2011 ; 96 136.[citado 2024 nov. 06 ]
Vancouver
Tognon R, Neves R, Nunes N, Gasparotto E, Kashima S, Covas DT, Santana M, Souto E, Zanichelli M, Velano C, Simoes BP, Souza AM de, Castro FA de. PRV-1 overexpression in essential thrombocythemia correlates with trail expression. Haematologica. 2011 ; 96 136.[citado 2024 nov. 06 ]
Trabalho de evento-resumo periodico
Apoptomirs expression profile in polycythemia vera patients (2011)
Nunes, S. de; Tognon, R.; Moura, L.; Kashima, S.; Covas, Dimas Tadeu; Santana, M.; Souto, E.; Zanichelli, M.; Simões, Belinda Pinto; Souza, Ana Maria de; Castro, Fabíola Attié de
Source: Haematologica. Conference titles: Congress of The European Hematology Association. Unidades: FMRP, FCFRP
Subjects: EXPRESSÃO GÊNICA, POLICITEMIA, APOPTOSE, FISIOPATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NUNES, S. de et al. Apoptomirs expression profile in polycythemia vera patients. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 06 nov. 2024. , 2011
APA
Nunes, S. de, Tognon, R., Moura, L., Kashima, S., Covas, D. T., Santana, M., et al. (2011). Apoptomirs expression profile in polycythemia vera patients. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Nunes S de, Tognon R, Moura L, Kashima S, Covas DT, Santana M, Souto E, Zanichelli M, Simões BP, Souza AM de, Castro FA de. Apoptomirs expression profile in polycythemia vera patients. Haematologica. 2011 ; 96 133.[citado 2024 nov. 06 ]
Vancouver
Nunes S de, Tognon R, Moura L, Kashima S, Covas DT, Santana M, Souto E, Zanichelli M, Simões BP, Souza AM de, Castro FA de. Apoptomirs expression profile in polycythemia vera patients. Haematologica. 2011 ; 96 133.[citado 2024 nov. 06 ]
Trabalho de evento-resumo periodico
Low expression of galectin-1 is correlated to down-regulation of bax pro-apoptotic gene expression in CD34+ hematopoietic stem cells from polycythemia vera patients (2011)
Moura, L.; Tognon, R.; Nunes, N.; Kashima, S.; Covas, Dimas Tadeu; Santana, M.; Souto, E.; Zanichelli, M.; Simões, Belinda Pinto; Souza, Ana Maria de; Dias-Baruffi, Marcelo; Castro, Fabíola Attié de
Source: Haematologica. Conference titles: Congress of The European Hematology Association. Unidades: FMRP, FCFRP
Subjects: EXPRESSÃO GÊNICA, POLICITEMIA, APOPTOSE, FISIOPATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOURA, L. et al. Low expression of galectin-1 is correlated to down-regulation of bax pro-apoptotic gene expression in CD34+ hematopoietic stem cells from polycythemia vera patients. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 06 nov. 2024. , 2011
APA
Moura, L., Tognon, R., Nunes, N., Kashima, S., Covas, D. T., Santana, M., et al. (2011). Low expression of galectin-1 is correlated to down-regulation of bax pro-apoptotic gene expression in CD34+ hematopoietic stem cells from polycythemia vera patients. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Moura L, Tognon R, Nunes N, Kashima S, Covas DT, Santana M, Souto E, Zanichelli M, Simões BP, Souza AM de, Dias-Baruffi M, Castro FA de. Low expression of galectin-1 is correlated to down-regulation of bax pro-apoptotic gene expression in CD34+ hematopoietic stem cells from polycythemia vera patients. Haematologica. 2011 ; 96 137.[citado 2024 nov. 06 ]
Vancouver
Moura L, Tognon R, Nunes N, Kashima S, Covas DT, Santana M, Souto E, Zanichelli M, Simões BP, Souza AM de, Dias-Baruffi M, Castro FA de. Low expression of galectin-1 is correlated to down-regulation of bax pro-apoptotic gene expression in CD34+ hematopoietic stem cells from polycythemia vera patients. Haematologica. 2011 ; 96 137.[citado 2024 nov. 06 ]
Artigo de periodico
Differential expression of apoptosis-related genes from death receptor pathway in chronic myeloproliferative diseases (2011)
Tognon, Raquel; Gasparotto, Elainy Patrícia Lino; Leroy, Janine Marie Gisele; Oliveira, Gislane Lelis Vilela; Neves, Renata Peres; Carrara, Rita de Cassia Viu; Kashima, Simone; Covas, Dimas Tadeu; Santana, Mary; Souto, Elizabeth Xisto; Zanichelli, Maria Aparecida; Velano, Carlos Eduardo Engel; Simoes, Belinda Pinto; Alberto, Fernando Lopes; Miyashiro, Kozue; Souza, Ana Maria de; Amarante-Mendes, João Gustavo Pessini ; Castro, Fabíola Attié de
Source: Journal of Clinical Pathology. Unidades: FMRP, FCFRP, ICB
Subjects: TRANSTORNOS MIELOPROLIFERATIVOS, APOPTOSE, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOGNON, Raquel et al. Differential expression of apoptosis-related genes from death receptor pathway in chronic myeloproliferative diseases. Journal of Clinical Pathology, v. 64, n. 1, p. 75-82, 2011Tradução . . Disponível em: https://doi.org/10.1136/jcp.2010.080895. Acesso em: 06 nov. 2024.
APA
Tognon, R., Gasparotto, E. P. L., Leroy, J. M. G., Oliveira, G. L. V., Neves, R. P., Carrara, R. de C. V., et al. (2011). Differential expression of apoptosis-related genes from death receptor pathway in chronic myeloproliferative diseases. Journal of Clinical Pathology, 64( 1), 75-82. doi:10.1136/jcp.2010.080895
NLM
Tognon R, Gasparotto EPL, Leroy JMG, Oliveira GLV, Neves RP, Carrara R de CV, Kashima S, Covas DT, Santana M, Souto EX, Zanichelli MA, Velano CEE, Simoes BP, Alberto FL, Miyashiro K, Souza AM de, Amarante-Mendes JGP, Castro FA de. Differential expression of apoptosis-related genes from death receptor pathway in chronic myeloproliferative diseases [Internet]. Journal of Clinical Pathology. 2011 ; 64( 1): 75-82.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1136/jcp.2010.080895
Vancouver
Tognon R, Gasparotto EPL, Leroy JMG, Oliveira GLV, Neves RP, Carrara R de CV, Kashima S, Covas DT, Santana M, Souto EX, Zanichelli MA, Velano CEE, Simoes BP, Alberto FL, Miyashiro K, Souza AM de, Amarante-Mendes JGP, Castro FA de. Differential expression of apoptosis-related genes from death receptor pathway in chronic myeloproliferative diseases [Internet]. Journal of Clinical Pathology. 2011 ; 64( 1): 75-82.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1136/jcp.2010.080895
Artigo de periodico
Deregulated expression of A1, Bcl-2, Bcl-xL, and Mcl-1 antiapoptotic proteins and Bid, Bad, and Bax proapoptotic genes in polycythemia vera patients (2011)
Gasparotto, Elainy Patricia Lino; Tognon, Raquel; Ferreira, Aline Fernanda; Oliveira, Gislane Lelis Vilela; Palma, Patrícia Vianna Bonini; Zanichelli, Maria Aparecida; Souto, Elizabeth Xisto; Velano, Carlos Eduardo Engel; Simoes, Belinda Pinto; Carrara, Rita de Cassia Viu; Kashima, Simone; Covas, Dimas Tadeu; Castro, Fabíola Attié de; Souza, Ana Maria de
Source: BJPS - Brazilian Journal of Pharmaceutical Sciences. Unidades: FMRP, FCFRP
Subjects: POLICITEMIA, MUTAÇÃO GENÉTICA, EXPRESSÃO GÊNICA, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GASPAROTTO, Elainy Patricia Lino et al. Deregulated expression of A1, Bcl-2, Bcl-xL, and Mcl-1 antiapoptotic proteins and Bid, Bad, and Bax proapoptotic genes in polycythemia vera patients. BJPS - Brazilian Journal of Pharmaceutical Sciences, v. 47, n. 4, p. 873-884, 2011Tradução . . Disponível em: https://doi.org/10.1590/S1984-82502011000400025. Acesso em: 06 nov. 2024.
APA
Gasparotto, E. P. L., Tognon, R., Ferreira, A. F., Oliveira, G. L. V., Palma, P. V. B., Zanichelli, M. A., et al. (2011). Deregulated expression of A1, Bcl-2, Bcl-xL, and Mcl-1 antiapoptotic proteins and Bid, Bad, and Bax proapoptotic genes in polycythemia vera patients. BJPS - Brazilian Journal of Pharmaceutical Sciences, 47( 4), 873-884. doi:10.1590/S1984-82502011000400025
NLM
Gasparotto EPL, Tognon R, Ferreira AF, Oliveira GLV, Palma PVB, Zanichelli MA, Souto EX, Velano CEE, Simoes BP, Carrara R de CV, Kashima S, Covas DT, Castro FA de, Souza AM de. Deregulated expression of A1, Bcl-2, Bcl-xL, and Mcl-1 antiapoptotic proteins and Bid, Bad, and Bax proapoptotic genes in polycythemia vera patients [Internet]. BJPS - Brazilian Journal of Pharmaceutical Sciences. 2011 ; 47( 4): 873-884.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1590/S1984-82502011000400025
Vancouver
Gasparotto EPL, Tognon R, Ferreira AF, Oliveira GLV, Palma PVB, Zanichelli MA, Souto EX, Velano CEE, Simoes BP, Carrara R de CV, Kashima S, Covas DT, Castro FA de, Souza AM de. Deregulated expression of A1, Bcl-2, Bcl-xL, and Mcl-1 antiapoptotic proteins and Bid, Bad, and Bax proapoptotic genes in polycythemia vera patients [Internet]. BJPS - Brazilian Journal of Pharmaceutical Sciences. 2011 ; 47( 4): 873-884.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1590/S1984-82502011000400025
Trabalho de evento-resumo periodico
Tyrosine kinase inhibitors modulate the apoptomirs: MIR-16, MIR-21, MIR-30E, MIR-145, MIR-142-3P, MIR-LET-7D, MIR-LET-7E and MIR-15A expression in BCR-ABL-positive cell (2011)
Ferreira, A.; Moura, L.; Simoes, Belinda Pinto; Silva Júnior, Wilson Araújo da; Kashima, S.; Covas, Dimas Tadeu; Souza, Ana Maria de; Castro, Fabíola Attié de
Source: Haematologica. Conference titles: Congress of The European Hematology Association. Unidades: FMRP, FCFRP
Subjects: EXPRESSÃO GÊNICA, APOPTOSE, ONCOGENES, LEUCEMIA MIELÓIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, A. et al. Tyrosine kinase inhibitors modulate the apoptomirs: MIR-16, MIR-21, MIR-30E, MIR-145, MIR-142-3P, MIR-LET-7D, MIR-LET-7E and MIR-15A expression in BCR-ABL-positive cell. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 06 nov. 2024. , 2011
APA
Ferreira, A., Moura, L., Simoes, B. P., Silva Júnior, W. A. da, Kashima, S., Covas, D. T., et al. (2011). Tyrosine kinase inhibitors modulate the apoptomirs: MIR-16, MIR-21, MIR-30E, MIR-145, MIR-142-3P, MIR-LET-7D, MIR-LET-7E and MIR-15A expression in BCR-ABL-positive cell. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Ferreira A, Moura L, Simoes BP, Silva Júnior WA da, Kashima S, Covas DT, Souza AM de, Castro FA de. Tyrosine kinase inhibitors modulate the apoptomirs: MIR-16, MIR-21, MIR-30E, MIR-145, MIR-142-3P, MIR-LET-7D, MIR-LET-7E and MIR-15A expression in BCR-ABL-positive cell. Haematologica. 2011 ; 96 597-598.[citado 2024 nov. 06 ]
Vancouver
Ferreira A, Moura L, Simoes BP, Silva Júnior WA da, Kashima S, Covas DT, Souza AM de, Castro FA de. Tyrosine kinase inhibitors modulate the apoptomirs: MIR-16, MIR-21, MIR-30E, MIR-145, MIR-142-3P, MIR-LET-7D, MIR-LET-7E and MIR-15A expression in BCR-ABL-positive cell. Haematologica. 2011 ; 96 597-598.[citado 2024 nov. 06 ]
Trabalho de evento-resumo
miR-142-3p expression is associated with imatinib resistance and c-flip anti-apoptotic gene expression in chronic myeloid leukemia patients (2010)
Ferreira, A. F.; Simoes, Belinda Pinto; Silva Júnior, Wilson Araújo da; Silva, I. T.; Zanichelli, M. A.; Colassanti, M. D.; Hamerschlak, N.; Covas, Dimas Tadeu; Kashima, S.; Souza, Ana Maria de; Castro, Fabíola Attié de
Source: Anais Eletrônicos. Conference titles: Congresso Brasileiro de Genética. Unidades: FMRP, FCFRP
Subjects: LEUCEMIA MIELOIDE AGUDA, EXPRESSÃO GÊNICA, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, A. F. et al. miR-142-3p expression is associated with imatinib resistance and c-flip anti-apoptotic gene expression in chronic myeloid leukemia patients. 2010, Anais.. Guarujá: SBG, 2010. Disponível em: http://web2.sbg.org.br/congress/sbg2008/resumos_index.asp. Acesso em: 06 nov. 2024.
APA
Ferreira, A. F., Simoes, B. P., Silva Júnior, W. A. da, Silva, I. T., Zanichelli, M. A., Colassanti, M. D., et al. (2010). miR-142-3p expression is associated with imatinib resistance and c-flip anti-apoptotic gene expression in chronic myeloid leukemia patients. In Anais Eletrônicos. Guarujá: SBG. Recuperado de http://web2.sbg.org.br/congress/sbg2008/resumos_index.asp
NLM
Ferreira AF, Simoes BP, Silva Júnior WA da, Silva IT, Zanichelli MA, Colassanti MD, Hamerschlak N, Covas DT, Kashima S, Souza AM de, Castro FA de. miR-142-3p expression is associated with imatinib resistance and c-flip anti-apoptotic gene expression in chronic myeloid leukemia patients [Internet]. Anais Eletrônicos. 2010 ;[citado 2024 nov. 06 ] Available from: http://web2.sbg.org.br/congress/sbg2008/resumos_index.asp
Vancouver
Ferreira AF, Simoes BP, Silva Júnior WA da, Silva IT, Zanichelli MA, Colassanti MD, Hamerschlak N, Covas DT, Kashima S, Souza AM de, Castro FA de. miR-142-3p expression is associated with imatinib resistance and c-flip anti-apoptotic gene expression in chronic myeloid leukemia patients [Internet]. Anais Eletrônicos. 2010 ;[citado 2024 nov. 06 ] Available from: http://web2.sbg.org.br/congress/sbg2008/resumos_index.asp

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Subjects

Source title

Indexado em

Non normalized affiliation